Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission

被引:21
作者
Dini, G
Valsecchi, MG
Micalizzi, C
Busca, A
Balduzzi, A
Arcese, W
Cesaro, S
Prete, A
Rabusin, M
Mazzolari, E
Di Bartolomeo, P
Sacchi, N
Pession, A
Giorgiani, G
Lanino, E
Lamparelli, T
Favre, C
Bosi, A
Manzitti, C
Galimberti, S
Locatelli, F
机构
[1] Ist Giannina Gaslini, UO Ematol & Oncol Pediat, I-16148 Genoa, Italy
[2] Univ Milano Bicocca, Dipartimento Med Clin Prevenz & Biotecnol Sanit, Milan, Italy
[3] Univ Turin, Osped Regina Margherita, Dipartimento Sci Pediat & Adolescentol, I-10124 Turin, Italy
[4] Univ Milano Bicocca, Osped S Gerardo Monza, Pediat Clin, Milan, Italy
[5] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy
[6] Univ Padua, Dipartimento Pediat, Clin Oncoematol Pediat, I-35100 Padua, Italy
[7] Osped S Orsola Malpighi, Dipartimento Sci Pediat Med & Chirurg, Bologna, Italy
[8] Univ Trieste, Pediat Clin, I-34127 Trieste, Italy
[9] Univ Brescia, Pediat Clin, I-25121 Brescia, Italy
[10] Univ Civile Pescara, Unita Terapia Intens Ematol Trapianto Emopoiet, Pescara, Italy
[11] Univ Pavia, IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[12] Osped Civile Genova, Div Ematol 2, Genoa, Italy
[13] Univ Pisa, Osped S Chiara, Pediat Clin, I-56100 Pisa, Italy
[14] Univ Florence, Cattedra Ematol, I-50121 Florence, Italy
关键词
childhood acute lymphoblastic leukemia; unrelated marrow donor; bone marrow transplantation; cord blood transplantation;
D O I
10.1038/sj.bmt.1704132
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We analyzed the outcome of 167 consecutive children with second CR acute lymphoblastic leukemia ( ALL), for whom an unrelated donor (UD) search was activated between 1989 and 1998 at a median time of 2 months after relapse. A suitable donor was identified for 70 patients at 1 year and 6.5 months before and after 1995 from search activation, respectively; a further leukemia relapse occurred during the search in 94 children at a median of 4 months after search activation, 36 of whom underwent UD ( 14) or other types of transplant ( 22), beyond second CR, while 58 died of progressive disease. Of 73 patients not experiencing a second relapse, 64 underwent UD ( 46) or other types of transplant ( 18), while nine proceeded with chemotherapy, and only four of them survived. The 3-year disease-free survival (DFS) from second CR for the 167 patients is 15.1%, whereas 3-year DFS after transplant for the 60 UD and 40 alternative donor transplanted children is 31.6 and 25.4%, respectively. In conclusion, a further relapse is the main factor adversely affecting outcome of children with second CR ALL. Thus, for these patients, the search should be activated early after relapse and either a UD or an alternative transplant should be performed as early as possible.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 32 条
[1]   Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J].
Aversa, F ;
Tabilio, A ;
Velardi, A ;
Cunningham, I ;
Terenzi, A ;
Falzetti, F ;
Ruggeri, L ;
Barbabietola, G ;
Aristei, C ;
Latini, P ;
Reisner, Y ;
Martelli, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) :1186-1193
[2]  
BALDUZZI A, 1995, BLOOD, V86, P3247
[3]   Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission:: evidence for long-term clinical and molecular remissions [J].
Balduzzi, A ;
Gaipa, G ;
Bonanomi, S ;
Dassi, M ;
Perseghin, P ;
Buscemi, F ;
D'Aniello, E ;
Rovelli, A ;
Schirò, R ;
Longoni, D ;
Rambaldi, A ;
Uderzo, C ;
Biondi, A .
LEUKEMIA, 2001, 15 (01) :50-56
[4]   MARROW TRANSPLANTATION FROM RELATED DONORS OTHER THAN HLA-IDENTICAL SIBLINGS [J].
BEATTY, PG ;
CLIFT, RA ;
MICKELSON, EM ;
NISPEROS, BB ;
FLOURNOY, N ;
MARTIN, PJ ;
SANDERS, JE ;
STEWART, P ;
BUCKNER, CD ;
STORB, R ;
THOMAS, ED ;
HANSEN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) :765-771
[5]   AUTOLOGOUS BONE-MARROW TRANSPLANTS COMPARED WITH CHEMOTHERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN A 2ND REMISSION - A MATCHED-PAIR ANALYSIS [J].
BORGMANN, A ;
SCHMID, H ;
HARTMANN, R ;
BAUMGARTEN, E ;
HERMANN, K ;
KLINGEBIEL, T ;
EBELL, W ;
ZINTL, F ;
GADNER, H ;
HENZE, G .
LANCET, 1995, 346 (8979) :873-876
[6]   SUPERIOR PROGNOSIS IN COMBINED COMPARED TO ISOLATED BONE-MARROW RELAPSES IN SALVAGE THERAPY OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
BUHRER, C ;
HARTMANN, R ;
FENGLER, R ;
DOPFER, R ;
GADNER, H ;
GEREIN, V ;
GOBEL, U ;
REITER, A ;
RITTER, J ;
HENZE, G .
MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (07) :470-476
[7]   UNRELATED BONE-MARROW DONOR TRANSPLANTS FOR CHILDREN WITH LEUKEMIA OR MYELODYSPLASIA [J].
CASPER, J ;
CAMITTA, B ;
TRUITT, R ;
BAXTERLOWE, LA ;
BUNIN, N ;
LAWTON, C ;
MURRAY, K ;
HUNTER, J ;
PIETRYGA, D ;
GARBRECHT, F ;
KEEVER, C ;
DROBYSKI, W ;
HOROWITZ, M ;
FLOMENBERG, N ;
ASH, R .
BLOOD, 1995, 85 (09) :2354-2363
[8]  
Conter V, 1998, HAEMATOLOGICA, V83, P791
[9]   EXTENDED INTRATHECAL METHOTREXATE MAY REPLACE CRANIAL IRRADIATION FOR PREVENTION OF CNS RELAPSE IN CHILDREN WITH INTERMEDIATE-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA TREATED WITH BERLIN-FRANKFURT-MUNSTER-BASED INTENSIVE CHEMOTHERAPY [J].
CONTER, V ;
ARICO, M ;
VALSECCHI, MG ;
RIZZARI, C ;
TESTI, AM ;
MESSINA, C ;
MORI, PG ;
MINIERO, R ;
COLELLA, R ;
BASSO, G ;
RONDELLI, R ;
PESSION, A ;
MASERA, G .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2497-2502
[10]   Unrelated donor bone marrow transplantation for children with acute leukemia [J].
Davies, SM ;
Wagner, JE ;
Shu, XO ;
Blazar, BR ;
Katsanis, E ;
Orchard, PJ ;
Kersey, JH ;
Dusenbery, KE ;
Weisdorf, DJ ;
McGlave, PB ;
Ramsay, NKC .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :557-565